nesthesia Vaginal delivery Labor epidural analgesia Caesarean section Neuroaxial anesthesia Common anesthesia Cesarean section indication Obstetric Elective Not specified499 338 (67.7) 147 (29.4) 14 (two.8) 499 ten (two) 395 (79.15) 77 (15.43) 17 (three.four) 499 129 (25.85) 107/129 (83) 370 (74.15) 367/370 (99.2) 3/370 (0.8) 370 174 (47.02) 133 (35.95) 63 (17.03)Conclusions: We didn’t uncover any important association in between heparin dose or the time from last dose to delivery and bleeding or thrombotic complications. There was a higher price of elective caesarean sections. The education in the pregnant lady for the optimal time for you to hold heparin prior to delivery is usually a secure approach without having considerably growing the risk of hemorrhagic or thrombotic complications. L. Perucci1; K. Pinto1; S. Silva1; E. Lage2; P. Teixeira2; A. Barbosa2; P. Alpoim2; L. Sousa2; L. Dusse2; A. TalvaniPB1300|Preeclampsia and Inflammatory Lipid Mediators: A Estrogen receptor Inhibitor review Longitudinal StudyFederal IKK-β Inhibitor Biological Activity University of Ouro Preto, Ouro Preto, Brazil; 2FederalUniversity of Minas Gerais, Belo Horizonte, Brazil PB1299|New Criteria for Assessing Hemostasis Disorders in Pregnant Ladies with Chronic Kidney Illness I. Vasilenko1,2; I. Nikolskaya3; E. Shestero3; V. Metelin1,2; D. KassinaBackground: The levels of pro-inflammatory (e.g. leukotriene B4-LTB4) and pro-resolving (e.g. lipoxin A4-LXA4, and resolvin D1-RvD1) lipid mediators happen to be lately investigated in preeclampsia (PE). Nonetheless, the production of these mediators all through gestation in both healthier and diseased contexts remains unclear. Aims: Investigate LTB4, LXA4, and RvD1 levels all through gestation in pregnant ladies with risk variables for PE who either developed (N = 11) or did not create (N = 7) the illness. Strategies: The ethics committee in the Federal University of Minas Gerais (#0618.0.203.0000) approved the study protocol and all participants provided written informed consent. LTB4, LXA4 and RvD1 plasma levels have been measured by immunoassays at 3 timepoints: 129, 209, and 304 weeks of gestation in both groups. Final results: Table 1 shows patients’ clinical characteristics.M.F. Vladimirsky Moscow Regional Clinical and Analysis Institute(MONIKI), Moscow, Russian Federation; 2A.N. Kosygin Russian State University, Moscow, Russian Federation; 3Moscow Regional Research Institute of Obstetrics and Gynecology (MONIIAG), Moscow, Russian Federation Background: The pregnancy of ladies with kidney illness is followed by elevated frequency of gestational complications development like endotheliosis, inflammation, oxidative pressure, and hemostatic impairments. Within this connection, a particular relevance could be the look for objective and informative criteria for blood clotting disorders in pregnant girls. Aims: The aim – to make less difficult the forecasting of attainable complications in mother in addition to a youngster, evaluation of their condition severity, and therapy efficacy.ABSTRACT961 of|TABLE 1 Clinical traits from the studied pregnant womenParameters Age (years)aPregnant girls who did not create PE (N = 17) 27 eight 23.6 (23.25.9) 1.0 (1.0.5) 112 11 71 9 114 9 71 4 115 (11020) 70 (708)aPregnant girls who created PE (N = 11) 27 four 28.7 (22.51.eight) two.0 (1.0.0) 119 7 77 8 116 15 78 13 140 (13571) 110 (8915)P 0.598 0.073 0.235 0.271 0.138 0.313 0.072 0.001 0.001BMI at study admission (kg/m2)b Number of gestationsb SBP at study admission (mmHg)a DBP at study admission (mmHg) 2nd SBP measurement (mmHg)a 2nd DBP measurement (mmHg)a SBP prior to delivery (mmHg)b DBP b
